The Dog Aging Project, which began in 2014, has enrolled 50,000 dogs and is driving clinical trials and commercial efforts to extend healthy canine lifespans, including a rapamycin trial slated for 2026 and FDA approval for Loyal’s experimental drug LOY-002. Read On…
